Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: Evidence from a Belgian real-world multicenter study

被引：0
|
作者：
Delombaerde, D. L. [1 ]
Oeste, C. L. [2 ]
Verbiest, A. T. L. [3 ]
Tack, L. [4 ]
Croes, L. [3 ]
Bassez, I. [2 ]
Hens, D. F. E. [2 ]
Franssen, C. [5 ]
Debruyne, P. R. [4 ]
Prenen, H. [3 ]
De Sutter, J. [6 ]
Vulsteke, C. [1 ]
机构：
[1] AZ Maria Middelares AZMMSJ, Integrated Canc Ctr Ghent, Ghent, Belgium
[2] LynxCare Clin Informat NV, Clin Dept, Leuven, Belgium
[3] Univ Hosp Antwerp, Med Oncol, Edegem, Belgium
[4] AZ Groeninge, Med Oncol, Campus Kennedylaan, Kortrijk, Belgium
[5] Univ Hosp Antwerp, Cardiol, Edegem, Belgium
[6] AZ Maria Middelares AZMMSJ, Cardiol, Ghent, Belgium
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1048P
引用
收藏
页码：S700 / S700
页数：1
相关论文
共 50 条
  • [41] Adoption of immune checkpoint inhibitors (ICIs) in bladder cancer: Findings from a real-world study in EU5
    Jindal, K.
    Mendoza, L.
    Moehler, T.
    Anger, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S595 - S595
  • [42] A Multicenter Study on the Challenges and Real-World Utilization of Immune Checkpoint Inhibitors in Resource-Constrained Settings: Insights and Implications from India
    Philips, Ashwin Oommen
    Cyriac, Sunu
    Unnikrishnan, P.
    Jose, Anil T.
    Rathnam, Krishnakumar
    Saju, S. V.
    Kayal, Smita
    Panda, Soumya Surath
    Moharana, Lalatendu
    Kilaru, Sindhu
    Sehrawat, Amit
    Sundriyal, Deepak
    Dhamija, Puneet
    Jain, Deepak
    Alice, K. Pamela
    Sachdeva, Jaineet
    Batta, Nishant
    Arora, Raman
    Arora, Yogesh
    Singh, Harpreet
    Anand, Mridul
    Sharma, Ishu
    Ganesan, Prasanth
    SOUTH ASIAN JOURNAL OF CANCER, 2025, 14 (01) : 77 - 80
  • [43] Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients
    Batlamous, Badiaa
    Lkhoyaali, Sihame
    Omri, Loubna
    Nguema-Mipaka, Magaly-Gwen-Farnely
    Khalis, Mohamed
    Inrhaoun, Hanane
    Naciri, Sarah
    El Ghissassi, Ibrahim
    Mrabti, Hind
    Boutayeb, Saber
    Errihani, Hassan
    JCO GLOBAL ONCOLOGY, 2025, 11
  • [44] Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer
    Eisner, Joel R.
    Beebe, Kirk D.
    Mayhew, Gregory M.
    Shibata, Yoichiro
    Guo, Yuelong
    Farhangfar, Carol
    Farhangfar, Farhang
    Uronis, Joshua M.
    Mooney, Jill
    V. Milburn, Michael
    Foureau, David
    White, Richard L.
    Amin, Asim
    Milla, Marcos E.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (08): : 894 - 903
  • [45] Real-world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer
    Qian, Xiaoyan
    Tao, Yunxia
    Chen, Haizhu
    Li, Xin
    Wang, Yaqin
    Xu, Xiaoming
    Li, Shuo
    Chen, Haoyu
    Cang, Shundong
    Liu, Yang
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [46] Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data
    Puca, Pierluigi
    Del Gaudio, Angelo
    Iaccarino, Jacopo
    Blasi, Valentina
    Coppola, Gaetano
    Laterza, Lucrezia
    Lopetuso, Loris Riccardo
    Colantuono, Stefania
    Gasbarrini, Antonio
    Scaldaferri, Franco
    Papa, Alfredo
    CANCERS, 2025, 17 (05)
  • [47] An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
    Nie, Caiyun
    Xu, Weifeng
    Chen, Beibei
    Lv, Huifang
    Wang, Jianzheng
    Liu, Yingjun
    He, Yunduan
    Wang, Saiqi
    Zhao, Jing
    Chen, Xiaobing
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 76 - 84
  • [48] Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022
    Wu, Si
    Bai, Hansheng
    Zhang, Ling
    He, Jiamin
    Luo, Xiangru
    Wang, Shiyi
    Fan, Guangjun
    Sun, Na
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [49] Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study
    Kim, Yong Joon
    Lee, Myeongjee
    Kim, Eun Hwa
    Lee, Seulkee
    Park, Sejung
    Shin, Sang Joon
    Jung, Inkyung
    Lee, Choong-kun
    CANCER LETTERS, 2024, 596
  • [50] Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors
    Dasari, Srilatha
    Tse, William
    Wang, Jiasheng
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1205 - 1208
12345